nodes	percent_of_prediction	percent_of_DWPC	metapath
Ramelteon—CYP3A4—Topotecan—ovarian cancer	0.0679	0.354	CbGbCtD
Ramelteon—CYP3A4—Vinorelbine—ovarian cancer	0.0478	0.25	CbGbCtD
Ramelteon—CYP3A4—Paclitaxel—ovarian cancer	0.0336	0.175	CbGbCtD
Ramelteon—Fatigue—Altretamine—ovarian cancer	0.0243	0.0407	CcSEcCtD
Ramelteon—CYP3A4—Docetaxel—ovarian cancer	0.0243	0.127	CbGbCtD
Ramelteon—Asthenia—Altretamine—ovarian cancer	0.0203	0.0339	CcSEcCtD
Ramelteon—Anaphylactoid reaction—Topotecan—ovarian cancer	0.0188	0.0314	CcSEcCtD
Ramelteon—Dizziness—Altretamine—ovarian cancer	0.0187	0.0312	CcSEcCtD
Ramelteon—CYP3A4—Doxorubicin—ovarian cancer	0.0181	0.0945	CbGbCtD
Ramelteon—Nausea—Altretamine—ovarian cancer	0.0168	0.028	CcSEcCtD
Ramelteon—Thinking abnormal—Paclitaxel—ovarian cancer	0.0157	0.0263	CcSEcCtD
Ramelteon—Mental disability—Paclitaxel—ovarian cancer	0.0125	0.0209	CcSEcCtD
Ramelteon—Arthralgia—Topotecan—ovarian cancer	0.00932	0.0156	CcSEcCtD
Ramelteon—Myalgia—Topotecan—ovarian cancer	0.00932	0.0156	CcSEcCtD
Ramelteon—Myalgia—Melphalan—ovarian cancer	0.00913	0.0153	CcSEcCtD
Ramelteon—Influenza—Paclitaxel—ovarian cancer	0.00904	0.0151	CcSEcCtD
Ramelteon—Thinking abnormal—Epirubicin—ovarian cancer	0.009	0.015	CcSEcCtD
Ramelteon—Anaphylactic shock—Topotecan—ovarian cancer	0.00894	0.0149	CcSEcCtD
Ramelteon—Anaphylactic shock—Melphalan—ovarian cancer	0.00875	0.0146	CcSEcCtD
Ramelteon—Fatigue—Chlorambucil—ovarian cancer	0.00865	0.0145	CcSEcCtD
Ramelteon—Upper respiratory tract infection—Paclitaxel—ovarian cancer	0.0084	0.014	CcSEcCtD
Ramelteon—Thinking abnormal—Doxorubicin—ovarian cancer	0.00833	0.0139	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Topotecan—ovarian cancer	0.00814	0.0136	CcSEcCtD
Ramelteon—Depression—Paclitaxel—ovarian cancer	0.00804	0.0134	CcSEcCtD
Ramelteon—Arthralgia—Vinorelbine—ovarian cancer	0.00797	0.0133	CcSEcCtD
Ramelteon—Myalgia—Vinorelbine—ovarian cancer	0.00797	0.0133	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Melphalan—ovarian cancer	0.00797	0.0133	CcSEcCtD
Ramelteon—Fatigue—Topotecan—ovarian cancer	0.0077	0.0129	CcSEcCtD
Ramelteon—Anaphylactic shock—Vinorelbine—ovarian cancer	0.00764	0.0128	CcSEcCtD
Ramelteon—Fatigue—Melphalan—ovarian cancer	0.00754	0.0126	CcSEcCtD
Ramelteon—Asthenia—Chlorambucil—ovarian cancer	0.0072	0.012	CcSEcCtD
Ramelteon—Mental disability—Epirubicin—ovarian cancer	0.00715	0.012	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Vinorelbine—ovarian cancer	0.00696	0.0116	CcSEcCtD
Ramelteon—Diarrhoea—Chlorambucil—ovarian cancer	0.00687	0.0115	CcSEcCtD
Ramelteon—Mental disability—Doxorubicin—ovarian cancer	0.00662	0.0111	CcSEcCtD
Ramelteon—Fatigue—Vinorelbine—ovarian cancer	0.00659	0.011	CcSEcCtD
Ramelteon—Asthenia—Topotecan—ovarian cancer	0.00641	0.0107	CcSEcCtD
Ramelteon—Asthenia—Melphalan—ovarian cancer	0.00628	0.0105	CcSEcCtD
Ramelteon—Anaphylactoid reaction—Epirubicin—ovarian cancer	0.00618	0.0103	CcSEcCtD
Ramelteon—Dysgeusia—Paclitaxel—ovarian cancer	0.00617	0.0103	CcSEcCtD
Ramelteon—Diarrhoea—Topotecan—ovarian cancer	0.00611	0.0102	CcSEcCtD
Ramelteon—Diarrhoea—Melphalan—ovarian cancer	0.00599	0.01	CcSEcCtD
Ramelteon—Nausea—Chlorambucil—ovarian cancer	0.00596	0.00997	CcSEcCtD
Ramelteon—Dizziness—Topotecan—ovarian cancer	0.00591	0.00988	CcSEcCtD
Ramelteon—Anaphylactoid reaction—Doxorubicin—ovarian cancer	0.00572	0.00956	CcSEcCtD
Ramelteon—Headache—Topotecan—ovarian cancer	0.0056	0.00936	CcSEcCtD
Ramelteon—Asthenia—Vinorelbine—ovarian cancer	0.00548	0.00917	CcSEcCtD
Ramelteon—Arthralgia—Paclitaxel—ovarian cancer	0.00536	0.00897	CcSEcCtD
Ramelteon—Myalgia—Paclitaxel—ovarian cancer	0.00536	0.00897	CcSEcCtD
Ramelteon—Nausea—Topotecan—ovarian cancer	0.00531	0.00887	CcSEcCtD
Ramelteon—Diarrhoea—Vinorelbine—ovarian cancer	0.00523	0.00874	CcSEcCtD
Ramelteon—Dysgeusia—Docetaxel—ovarian cancer	0.00523	0.00874	CcSEcCtD
Ramelteon—Nausea—Melphalan—ovarian cancer	0.0052	0.00869	CcSEcCtD
Ramelteon—Influenza—Epirubicin—ovarian cancer	0.00517	0.00864	CcSEcCtD
Ramelteon—Anaphylactic shock—Paclitaxel—ovarian cancer	0.00514	0.0086	CcSEcCtD
Ramelteon—Dizziness—Vinorelbine—ovarian cancer	0.00505	0.00845	CcSEcCtD
Ramelteon—Upper respiratory tract infection—Epirubicin—ovarian cancer	0.0048	0.00803	CcSEcCtD
Ramelteon—Headache—Vinorelbine—ovarian cancer	0.00479	0.00801	CcSEcCtD
Ramelteon—Influenza—Doxorubicin—ovarian cancer	0.00478	0.008	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.00468	0.00783	CcSEcCtD
Ramelteon—Insomnia—Paclitaxel—ovarian cancer	0.00465	0.00777	CcSEcCtD
Ramelteon—Somnolence—Paclitaxel—ovarian cancer	0.00457	0.00764	CcSEcCtD
Ramelteon—Arthralgia—Docetaxel—ovarian cancer	0.00455	0.0076	CcSEcCtD
Ramelteon—Myalgia—Docetaxel—ovarian cancer	0.00455	0.0076	CcSEcCtD
Ramelteon—Nausea—Vinorelbine—ovarian cancer	0.00454	0.00759	CcSEcCtD
Ramelteon—Upper respiratory tract infection—Doxorubicin—ovarian cancer	0.00445	0.00743	CcSEcCtD
Ramelteon—Fatigue—Paclitaxel—ovarian cancer	0.00443	0.00741	CcSEcCtD
Ramelteon—Anaphylactic shock—Docetaxel—ovarian cancer	0.00436	0.00729	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.00397	0.00664	CcSEcCtD
Ramelteon—Insomnia—Docetaxel—ovarian cancer	0.00394	0.00659	CcSEcCtD
Ramelteon—Somnolence—Docetaxel—ovarian cancer	0.00387	0.00648	CcSEcCtD
Ramelteon—Fatigue—Docetaxel—ovarian cancer	0.00376	0.00628	CcSEcCtD
Ramelteon—Asthenia—Paclitaxel—ovarian cancer	0.00369	0.00617	CcSEcCtD
Ramelteon—Dysgeusia—Epirubicin—ovarian cancer	0.00353	0.0059	CcSEcCtD
Ramelteon—Diarrhoea—Paclitaxel—ovarian cancer	0.00352	0.00588	CcSEcCtD
Ramelteon—Dizziness—Paclitaxel—ovarian cancer	0.0034	0.00568	CcSEcCtD
Ramelteon—Dysgeusia—Doxorubicin—ovarian cancer	0.00326	0.00546	CcSEcCtD
Ramelteon—Headache—Paclitaxel—ovarian cancer	0.00322	0.00539	CcSEcCtD
Ramelteon—Asthenia—Docetaxel—ovarian cancer	0.00313	0.00523	CcSEcCtD
Ramelteon—Arthralgia—Epirubicin—ovarian cancer	0.00307	0.00513	CcSEcCtD
Ramelteon—Myalgia—Epirubicin—ovarian cancer	0.00307	0.00513	CcSEcCtD
Ramelteon—Nausea—Paclitaxel—ovarian cancer	0.00305	0.00511	CcSEcCtD
Ramelteon—Diarrhoea—Docetaxel—ovarian cancer	0.00298	0.00499	CcSEcCtD
Ramelteon—Anaphylactic shock—Epirubicin—ovarian cancer	0.00294	0.00491	CcSEcCtD
Ramelteon—Dizziness—Docetaxel—ovarian cancer	0.00288	0.00482	CcSEcCtD
Ramelteon—Arthralgia—Doxorubicin—ovarian cancer	0.00284	0.00474	CcSEcCtD
Ramelteon—Myalgia—Doxorubicin—ovarian cancer	0.00284	0.00474	CcSEcCtD
Ramelteon—Headache—Docetaxel—ovarian cancer	0.00273	0.00456	CcSEcCtD
Ramelteon—Anaphylactic shock—Doxorubicin—ovarian cancer	0.00272	0.00455	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.00268	0.00448	CcSEcCtD
Ramelteon—Insomnia—Epirubicin—ovarian cancer	0.00266	0.00444	CcSEcCtD
Ramelteon—Somnolence—Epirubicin—ovarian cancer	0.00261	0.00437	CcSEcCtD
Ramelteon—Nausea—Docetaxel—ovarian cancer	0.00259	0.00433	CcSEcCtD
Ramelteon—Fatigue—Epirubicin—ovarian cancer	0.00253	0.00424	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.00248	0.00414	CcSEcCtD
Ramelteon—Insomnia—Doxorubicin—ovarian cancer	0.00246	0.00411	CcSEcCtD
Ramelteon—Somnolence—Doxorubicin—ovarian cancer	0.00242	0.00404	CcSEcCtD
Ramelteon—Fatigue—Doxorubicin—ovarian cancer	0.00234	0.00392	CcSEcCtD
Ramelteon—Asthenia—Epirubicin—ovarian cancer	0.00211	0.00353	CcSEcCtD
Ramelteon—Diarrhoea—Epirubicin—ovarian cancer	0.00201	0.00336	CcSEcCtD
Ramelteon—Asthenia—Doxorubicin—ovarian cancer	0.00195	0.00326	CcSEcCtD
Ramelteon—Dizziness—Epirubicin—ovarian cancer	0.00194	0.00325	CcSEcCtD
Ramelteon—Diarrhoea—Doxorubicin—ovarian cancer	0.00186	0.00311	CcSEcCtD
Ramelteon—Headache—Epirubicin—ovarian cancer	0.00184	0.00308	CcSEcCtD
Ramelteon—Dizziness—Doxorubicin—ovarian cancer	0.0018	0.00301	CcSEcCtD
Ramelteon—Nausea—Epirubicin—ovarian cancer	0.00175	0.00292	CcSEcCtD
Ramelteon—Headache—Doxorubicin—ovarian cancer	0.0017	0.00285	CcSEcCtD
Ramelteon—Nausea—Doxorubicin—ovarian cancer	0.00162	0.0027	CcSEcCtD
Ramelteon—MTNR1B—G alpha (i) signalling events—CXCL8—ovarian cancer	0.00124	0.00592	CbGpPWpGaD
Ramelteon—MTNR1A—G alpha (i) signalling events—CXCL8—ovarian cancer	0.00124	0.00592	CbGpPWpGaD
Ramelteon—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1B1—ovarian cancer	0.00124	0.00588	CbGpPWpGaD
Ramelteon—CYP2C19—Oxidation by Cytochrome P450—CYP1B1—ovarian cancer	0.00122	0.0058	CbGpPWpGaD
Ramelteon—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1B1—ovarian cancer	0.00119	0.00567	CbGpPWpGaD
Ramelteon—CYP1A2—Tryptophan metabolism—CYP1B1—ovarian cancer	0.00119	0.00567	CbGpPWpGaD
Ramelteon—CYP1A2—Aryl Hydrocarbon Receptor—CYP1B1—ovarian cancer	0.00119	0.00567	CbGpPWpGaD
Ramelteon—CYP1A2—Estrogen Receptor Pathway—STAT3—ovarian cancer	0.00115	0.00548	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—DOK1—ovarian cancer	0.00112	0.00531	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—DOK1—ovarian cancer	0.00112	0.00531	CbGpPWpGaD
Ramelteon—CYP1A2—Arachidonic acid metabolism—CYP1B1—ovarian cancer	0.00112	0.0053	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—PPP1CC—ovarian cancer	0.00105	0.00499	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—PPP1CC—ovarian cancer	0.00105	0.00499	CbGpPWpGaD
Ramelteon—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—ovarian cancer	0.00101	0.00482	CbGpPWpGaD
Ramelteon—CYP2C19—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	0.001	0.00477	CbGpPWpGaD
Ramelteon—MTNR1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—ovarian cancer	0.000989	0.0047	CbGpPWpGaD
Ramelteon—MTNR1B—Class A/1 (Rhodopsin-like receptors)—CXCL8—ovarian cancer	0.000989	0.0047	CbGpPWpGaD
Ramelteon—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ovarian cancer	0.000965	0.00459	CbGpPWpGaD
Ramelteon—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1B1—ovarian cancer	0.000964	0.00458	CbGpPWpGaD
Ramelteon—CYP1A2—Oxidation by Cytochrome P450—CYP1B1—ovarian cancer	0.000951	0.00452	CbGpPWpGaD
Ramelteon—CYP3A4—Tryptophan metabolism—CYP1B1—ovarian cancer	0.00092	0.00437	CbGpPWpGaD
Ramelteon—MTNR1B—Circadian rythm related genes—TP53—ovarian cancer	0.000865	0.00411	CbGpPWpGaD
Ramelteon—MTNR1A—Circadian rythm related genes—TP53—ovarian cancer	0.000865	0.00411	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—HDAC6—ovarian cancer	0.000795	0.00378	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—HDAC6—ovarian cancer	0.000795	0.00378	CbGpPWpGaD
Ramelteon—MTNR1A—Circadian rythm related genes—IL6—ovarian cancer	0.000792	0.00377	CbGpPWpGaD
Ramelteon—MTNR1B—Circadian rythm related genes—IL6—ovarian cancer	0.000792	0.00377	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—PPP2R1A—ovarian cancer	0.000784	0.00373	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—PPP2R1A—ovarian cancer	0.000784	0.00373	CbGpPWpGaD
Ramelteon—CYP1A2—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	0.000781	0.00371	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR ligand binding—CXCL8—ovarian cancer	0.000753	0.00358	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR ligand binding—CXCL8—ovarian cancer	0.000753	0.00358	CbGpPWpGaD
Ramelteon—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—ovarian cancer	0.000748	0.00356	CbGpPWpGaD
Ramelteon—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—ovarian cancer	0.000744	0.00354	CbGpPWpGaD
Ramelteon—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—ovarian cancer	0.000734	0.00349	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—YAP1—ovarian cancer	0.000704	0.00335	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—YAP1—ovarian cancer	0.000704	0.00335	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—XIAP—ovarian cancer	0.000689	0.00328	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—XIAP—ovarian cancer	0.000689	0.00328	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—SMARCA4—ovarian cancer	0.000672	0.00319	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—SMARCA4—ovarian cancer	0.000672	0.00319	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—EREG—ovarian cancer	0.000656	0.00312	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—EREG—ovarian cancer	0.000656	0.00312	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—PGR—ovarian cancer	0.000614	0.00292	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—PGR—ovarian cancer	0.000614	0.00292	CbGpPWpGaD
Ramelteon—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	0.000603	0.00287	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR downstream signaling—PIK3CG—ovarian cancer	0.000578	0.00275	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR downstream signaling—PIK3CG—ovarian cancer	0.000578	0.00275	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—PARP1—ovarian cancer	0.000571	0.00272	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—PARP1—ovarian cancer	0.000571	0.00272	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—IL6ST—ovarian cancer	0.000546	0.0026	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—IL6ST—ovarian cancer	0.000546	0.0026	CbGpPWpGaD
Ramelteon—CYP2C19—Biological oxidations—CYP1B1—ovarian cancer	0.000533	0.00253	CbGpPWpGaD
Ramelteon—CYP2C19—Metapathway biotransformation—CYP1B1—ovarian cancer	0.000525	0.0025	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—PIK3CG—ovarian cancer	0.000525	0.0025	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—PIK3CG—ovarian cancer	0.000525	0.0025	CbGpPWpGaD
Ramelteon—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—ovarian cancer	0.000509	0.00242	CbGpPWpGaD
Ramelteon—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—ovarian cancer	0.000509	0.00242	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR downstream signaling—PIK3CD—ovarian cancer	0.000508	0.00242	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR downstream signaling—PIK3CD—ovarian cancer	0.000508	0.00242	CbGpPWpGaD
Ramelteon—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—ovarian cancer	0.000498	0.00237	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—PPP2R1A—ovarian cancer	0.000463	0.0022	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—PPP2R1A—ovarian cancer	0.000463	0.0022	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—PIK3CD—ovarian cancer	0.000462	0.00219	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—PIK3CD—ovarian cancer	0.000462	0.00219	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR downstream signaling—PIK3CB—ovarian cancer	0.000443	0.00211	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR downstream signaling—PIK3CB—ovarian cancer	0.000443	0.00211	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR downstream signaling—CXCL8—ovarian cancer	0.000426	0.00202	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR downstream signaling—CXCL8—ovarian cancer	0.000426	0.00202	CbGpPWpGaD
Ramelteon—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—ovarian cancer	0.000423	0.00201	CbGpPWpGaD
Ramelteon—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—ovarian cancer	0.000418	0.00199	CbGpPWpGaD
Ramelteon—CYP1A2—Biological oxidations—CYP1B1—ovarian cancer	0.000415	0.00197	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	0.000411	0.00195	CbGpPWpGaD
Ramelteon—CYP1A2—Metapathway biotransformation—CYP1B1—ovarian cancer	0.000409	0.00195	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR downstream signaling—IL2—ovarian cancer	0.000407	0.00193	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR downstream signaling—IL2—ovarian cancer	0.000407	0.00193	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—PIK3CB—ovarian cancer	0.000402	0.00191	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—PIK3CB—ovarian cancer	0.000402	0.00191	CbGpPWpGaD
Ramelteon—CYP1A2—Aryl Hydrocarbon Receptor—MYC—ovarian cancer	0.000389	0.00185	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—CXCL8—ovarian cancer	0.000387	0.00184	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—CXCL8—ovarian cancer	0.000387	0.00184	CbGpPWpGaD
Ramelteon—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—ovarian cancer	0.000381	0.00181	CbGpPWpGaD
Ramelteon—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—ovarian cancer	0.000381	0.00181	CbGpPWpGaD
Ramelteon—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—ovarian cancer	0.000381	0.00181	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—IL2—ovarian cancer	0.000369	0.00176	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—IL2—ovarian cancer	0.000369	0.00176	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—TERT—ovarian cancer	0.000368	0.00175	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—TERT—ovarian cancer	0.000368	0.00175	CbGpPWpGaD
Ramelteon—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—ovarian cancer	0.00036	0.00171	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—CAV1—ovarian cancer	0.00034	0.00162	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—CAV1—ovarian cancer	0.00034	0.00162	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—ESR1—ovarian cancer	0.000328	0.00156	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—ESR1—ovarian cancer	0.000328	0.00156	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—NME2—ovarian cancer	0.000325	0.00154	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—IL6ST—ovarian cancer	0.000323	0.00153	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—IL6ST—ovarian cancer	0.000323	0.00153	CbGpPWpGaD
Ramelteon—CYP3A4—Biological oxidations—CYP1B1—ovarian cancer	0.00032	0.00152	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	0.00032	0.00152	CbGpPWpGaD
Ramelteon—CYP3A4—Metapathway biotransformation—CYP1B1—ovarian cancer	0.000316	0.0015	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—APC—ovarian cancer	0.00031	0.00147	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—PIK3CG—ovarian cancer	0.00031	0.00147	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—PIK3CG—ovarian cancer	0.00031	0.00147	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—APC—ovarian cancer	0.00031	0.00147	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—NRAS—ovarian cancer	0.00031	0.00147	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—NRAS—ovarian cancer	0.00031	0.00147	CbGpPWpGaD
Ramelteon—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—ovarian cancer	0.000306	0.00145	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—MAPK3—ovarian cancer	0.000297	0.00141	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—MAPK3—ovarian cancer	0.000297	0.00141	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—MAPK1—ovarian cancer	0.000283	0.00134	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—MAPK1—ovarian cancer	0.000283	0.00134	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—EGFR—ovarian cancer	0.000283	0.00134	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—EGFR—ovarian cancer	0.000283	0.00134	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	0.000275	0.00131	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—PIK3CD—ovarian cancer	0.000273	0.0013	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—PIK3CD—ovarian cancer	0.000273	0.0013	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR downstream signaling—PIK3CA—ovarian cancer	0.00027	0.00128	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR downstream signaling—PIK3CA—ovarian cancer	0.00027	0.00128	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—KRAS—ovarian cancer	0.000267	0.00127	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—KRAS—ovarian cancer	0.000267	0.00127	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—NME2—ovarian cancer	0.000253	0.0012	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—PIK3CA—ovarian cancer	0.000245	0.00117	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—PIK3CA—ovarian cancer	0.000245	0.00117	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—ERBB2—ovarian cancer	0.000241	0.00115	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—ERBB2—ovarian cancer	0.000241	0.00115	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—MTOR—ovarian cancer	0.000238	0.00113	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—PIK3CB—ovarian cancer	0.000238	0.00113	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—PIK3CB—ovarian cancer	0.000238	0.00113	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—MTOR—ovarian cancer	0.000238	0.00113	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—CXCL8—ovarian cancer	0.000228	0.00109	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—CXCL8—ovarian cancer	0.000228	0.00109	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—HRAS—ovarian cancer	0.000227	0.00108	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—HRAS—ovarian cancer	0.000227	0.00108	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	0.000225	0.00107	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—CDKN1B—ovarian cancer	0.000223	0.00106	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—CDKN1B—ovarian cancer	0.000223	0.00106	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR downstream signaling—AKT1—ovarian cancer	0.000221	0.00105	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR downstream signaling—AKT1—ovarian cancer	0.000221	0.00105	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—CASP3—ovarian cancer	0.000219	0.00104	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—CASP3—ovarian cancer	0.000219	0.00104	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—IL2—ovarian cancer	0.000218	0.00104	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—IL2—ovarian cancer	0.000218	0.00104	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—IL6—ovarian cancer	0.000217	0.00103	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—IL6—ovarian cancer	0.000217	0.00103	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	0.000215	0.00102	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—CCND1—ovarian cancer	0.000213	0.00101	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—CCND1—ovarian cancer	0.000213	0.00101	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—CTNNB1—ovarian cancer	0.000211	0.001	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—CTNNB1—ovarian cancer	0.000211	0.001	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—CYTB—ovarian cancer	0.000209	0.000995	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—MMP9—ovarian cancer	0.000207	0.000982	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—MMP9—ovarian cancer	0.000207	0.000982	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—PTEN—ovarian cancer	0.000205	0.000976	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—PTEN—ovarian cancer	0.000205	0.000976	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	0.000205	0.000972	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—AKT1—ovarian cancer	0.0002	0.000953	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—AKT1—ovarian cancer	0.0002	0.000953	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—NME2—ovarian cancer	0.000195	0.000928	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—VEGFA—ovarian cancer	0.000185	0.000882	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—VEGFA—ovarian cancer	0.000185	0.000882	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—STAT3—ovarian cancer	0.000184	0.000873	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—STAT3—ovarian cancer	0.000184	0.000873	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—NRAS—ovarian cancer	0.000183	0.000871	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—NRAS—ovarian cancer	0.000183	0.000871	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—BRIP1—ovarian cancer	0.000183	0.00087	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—PPP1CC—ovarian cancer	0.000183	0.00087	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—MAPK3—ovarian cancer	0.000175	0.000834	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—MAPK3—ovarian cancer	0.000175	0.000834	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	0.000175	0.000832	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—MYC—ovarian cancer	0.000171	0.000811	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—MYC—ovarian cancer	0.000171	0.000811	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—MAPK1—ovarian cancer	0.000167	0.000794	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—MAPK1—ovarian cancer	0.000167	0.000794	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—EGFR—ovarian cancer	0.000167	0.000794	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—EGFR—ovarian cancer	0.000167	0.000794	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—CYTB—ovarian cancer	0.000163	0.000775	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	0.000159	0.000758	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—KRAS—ovarian cancer	0.000158	0.00075	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—KRAS—ovarian cancer	0.000158	0.00075	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—PIK3CA—ovarian cancer	0.000145	0.000689	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—PIK3CA—ovarian cancer	0.000145	0.000689	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—PPP1CC—ovarian cancer	0.000143	0.000678	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—BRIP1—ovarian cancer	0.000143	0.000678	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—TP53—ovarian cancer	0.00014	0.000666	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—TP53—ovarian cancer	0.00014	0.000666	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—HRAS—ovarian cancer	0.000134	0.000637	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—HRAS—ovarian cancer	0.000134	0.000637	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	0.000133	0.000634	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—IL6—ovarian cancer	0.000128	0.00061	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—IL6—ovarian cancer	0.000128	0.00061	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—CYTB—ovarian cancer	0.000126	0.000598	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—YAP1—ovarian cancer	0.000123	0.000583	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	0.000121	0.000577	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—AKT1—ovarian cancer	0.000118	0.000563	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—AKT1—ovarian cancer	0.000118	0.000563	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—PPP1CC—ovarian cancer	0.00011	0.000523	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—BRIP1—ovarian cancer	0.00011	0.000523	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	0.000107	0.000507	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	0.000104	0.000494	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—FASN—ovarian cancer	0.0001	0.000476	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—SLC5A5—ovarian cancer	9.84e-05	0.000468	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—YAP1—ovarian cancer	9.56e-05	0.000454	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—SLC2A1—ovarian cancer	9.5e-05	0.000452	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	9.46e-05	0.00045	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	9.3e-05	0.000442	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—CYP1B1—ovarian cancer	9.11e-05	0.000433	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	8.32e-05	0.000395	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—PPP2R1A—ovarian cancer	8.08e-05	0.000384	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	8.04e-05	0.000382	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—FASN—ovarian cancer	7.79e-05	0.000371	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—SLC5A5—ovarian cancer	7.66e-05	0.000364	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—ABCB1—ovarian cancer	7.5e-05	0.000357	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—SLC2A1—ovarian cancer	7.4e-05	0.000352	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—YAP1—ovarian cancer	7.38e-05	0.000351	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—TYMS—ovarian cancer	7.37e-05	0.00035	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	7.25e-05	0.000345	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—CYP1B1—ovarian cancer	7.1e-05	0.000337	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—PPP2R1A—ovarian cancer	6.29e-05	0.000299	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	6.26e-05	0.000298	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—FASN—ovarian cancer	6.01e-05	0.000286	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—CAV1—ovarian cancer	5.94e-05	0.000282	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—SLC5A5—ovarian cancer	5.92e-05	0.000281	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—ABCB1—ovarian cancer	5.84e-05	0.000278	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—TYMS—ovarian cancer	5.74e-05	0.000273	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—SLC2A1—ovarian cancer	5.71e-05	0.000272	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	5.67e-05	0.00027	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—CYP1B1—ovarian cancer	5.48e-05	0.00026	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—PIK3CG—ovarian cancer	5.41e-05	0.000257	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	4.86e-05	0.000231	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—PIK3CD—ovarian cancer	4.75e-05	0.000226	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—CAV1—ovarian cancer	4.62e-05	0.00022	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—ABCB1—ovarian cancer	4.51e-05	0.000214	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—TYMS—ovarian cancer	4.43e-05	0.000211	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	4.42e-05	0.00021	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—PIK3CG—ovarian cancer	4.21e-05	0.0002	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—PIK3CB—ovarian cancer	4.14e-05	0.000197	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—PIK3CD—ovarian cancer	3.7e-05	0.000176	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—PTEN—ovarian cancer	3.58e-05	0.00017	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—CAV1—ovarian cancer	3.57e-05	0.00017	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—PIK3CG—ovarian cancer	3.25e-05	0.000155	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—PIK3CB—ovarian cancer	3.23e-05	0.000153	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—PIK3CD—ovarian cancer	2.86e-05	0.000136	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—PTEN—ovarian cancer	2.79e-05	0.000133	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—PIK3CA—ovarian cancer	2.53e-05	0.00012	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—PIK3CB—ovarian cancer	2.49e-05	0.000118	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—PTEN—ovarian cancer	2.15e-05	0.000102	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—AKT1—ovarian cancer	2.06e-05	9.81e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—PIK3CA—ovarian cancer	1.97e-05	9.36e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—AKT1—ovarian cancer	1.61e-05	7.64e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—PIK3CA—ovarian cancer	1.52e-05	7.22e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—AKT1—ovarian cancer	1.24e-05	5.9e-05	CbGpPWpGaD
